Screener
NovoCure NVCR Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| -$10.44M+72.0% | -$15.66M+61.0% | -$71.14M-107% | -$24.5M+62.8% | -$37.27M-21.9% | ||
| $4.42M+20.6% | $4.31M+25.1% | $4.12M+24.0% | $4.22M+35.9% | $3.66M+49.0% | ||
| $17.48M-40.4% | $17.01M-34.9% | $63.01M+113% | $19.82M-68.4% | $29.32M-6.5% | ||
| $22.67M+10.2% | $8.13M+151% | -$13.52M+62.1% | -$18M-422% | $20.57M+98.3% | ||
| $6.92M+22.4% | $6.92M+26.1% | $5.15M-51.4% | $4.9M-45.2% | $5.66M-47.1% | ||
| -$23.24M-133% | -$6.38M-118% | $7.75M+220% | $336.33M+1,614% | $71.44M+601% | ||
| $0-100% | $0— | $0— | $0— | $99.98M— | ||
| $0— | $0— | $0— | $560.95M— | $0— | ||
| $3.64M-96.4% | $4.55M+90.5% | -$166K-103% | -$559.49M-20,938% | $100.52M+100,417% | ||
| $3.22M-98.3% | $6.29M-72.3% | -$6.07M+83.5% | -$241.25M-944% | $192.51M+827% | ||
| $15.75M+5.5% | $1.22M+106% | -$18.67M+59.7% | -$22.9M-84.8% | $14.92M+4,960% |
FAQ
- How much cash does NovoCure generate?
- NovoCure (NVCR) generated -$722.0K in operating cash flow over the trailing twelve months.
- What is NovoCure's free cash flow?
- After $23.9M of capital expenditures, NovoCure's free cash flow was -$24.6M over the trailing twelve months, up 62.2% year over year.
- Where does NovoCure's cash flow data come from?
- Every line is extracted from NovoCure's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
